← Leaderboards
Missag Hagop Parseghian
Rubicon Biotechnology, Inc.
$951,821
Attributed
$1,397,888
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $573.5K · FY2013–17$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$1,397,888 · 4
By mechanism
R43$728,788 · 3
R21$669,100 · 1
Top collaborators
- Robert Nishimura3 shared
- Richard Weisbart3 shared
Others in their field
Top investigators on “Toxic Effect”
- George R Seage · Abt Associates, Inc.$224,114,540
- Peter C Adamson · National Childhood Cancer Foundation$126,756,857
- Gregory H Reaman · National Childhood Cancer Foundation$123,836,183
- Carol Nesel · Westat$116,355,411
- Mary M Horowitz · Medical College Of Wisconsin$90,165,506
- Barney Sparrow · Battelle Memorial Institute$88,494,220
Research focus
Toxic EffectAntibodiesResearch ProposalsCell DeathMedicalExtracellularIn VivoMissionTissuesInnovationFundingCellsChimeric ProteinsMass Spectrum AnalysisCessation Of LifeIntracellular TransportCell SurvivalInfarctionInjuryIn VitroCell InjuryEffectivenessDoseDrug Formulations
Grant awards (6)
Targeted Hsp72 as a Therapeutic for Central Retinal Artery Occlusion$212,466
R43 · FY2017 · EY · contact PI
Modified Annexin V for immunostimulation of the tumor microenvironment$292,989
R43 · FY2015 · CA · contact PI
Intracellular targeting Hsp70 for pulmonary cytoprotection after toxin inhalation$300,186
R21 · FY2014 · ES · contact PI
Intracellular targeting Hsp70 for myocardial cytoprotection after an infarction$223,333
R43 · FY2014 · HL · contact PI
Intracellular targeting Hsp70 for pulmonary cytoprotection after toxin inhalation$50,000
R21 · FY2014 · ES · contact PI
Intracellular targeting Hsp70 for pulmonary cytoprotection after toxin inhalation$318,914
R21 · FY2013 · ES · contact PI